Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Hemolytic anemia comes in different types, such as sickle cell disorder, thalassemia, enzyme disorders, and other genetic conditions
Weiss B, Widemann BC, Wolters P, et al
JAMA 2021;325:140313.ArticlePubMedPMC 49
The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible
Journal of Diabetes Research, 25(6), 234-240
US$ 27.95
US$ 26.89
US$ 28.07
US$ 28.21
US$ 22.72
US$ 23.30
